PLUS THERAPEUTICS, INC. Files Material Definitive Agreement

Ticker: PSTV · Form: 8-K · Filed: Jun 17, 2025 · CIK: 1095981

Plus Therapeutics, Inc. 8-K Filing Summary
FieldDetail
CompanyPlus Therapeutics, Inc. (PSTV)
Form Type8-K
Filed DateJun 17, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: material-definitive-agreement, corporate-filing

TL;DR

PLUS THERAPEUTICS (PSTX) filed an 8-K for a material definitive agreement. Big news pending.

AI Summary

On June 17, 2025, PLUS THERAPEUTICS, INC. filed an 8-K report detailing a material definitive agreement. The company, formerly known as CYTORI THERAPEUTICS, INC. and MACROPORE INC, is incorporated in Delaware and headquartered in Houston, Texas.

Why It Matters

This filing indicates a significant new contract or partnership for PLUS THERAPEUTICS, INC., which could impact its future operations and financial performance.

Risk Assessment

Risk Level: medium — Material definitive agreements can introduce significant opportunities or risks, depending on the terms and implications for the company's business strategy and financial health.

Key Players & Entities

  • PLUS THERAPEUTICS, INC. (company) — Registrant
  • CYTORI THERAPEUTICS, INC. (company) — Former Company Name
  • MACROPORE INC (company) — Former Company Name
  • June 17, 2025 (date) — Date of Report

FAQ

What is the nature of the material definitive agreement filed by PLUS THERAPEUTICS, INC.?

The 8-K filing indicates the entry into a material definitive agreement, but the specific details of the agreement are not provided in the summary information.

When was this material definitive agreement entered into?

The report was filed on June 17, 2025, and this date is also listed as the date of the earliest event reported, suggesting the agreement was entered into on or around June 17, 2025.

What were the previous names of PLUS THERAPEUTICS, INC.?

PLUS THERAPEUTICS, INC. was formerly known as CYTORI THERAPEUTICS, INC. and MACROPORE INC.

Where is PLUS THERAPEUTICS, INC. incorporated and what is its principal executive office address?

The company is incorporated in Delaware and its principal executive office is located at 2710 Reed Road, Suite 160, Houston, Texas 77051.

What is the SIC code for PLUS THERAPEUTICS, INC.?

The Standard Industrial Classification (SIC) code for PLUS THERAPEUTICS, INC. is 3841, which corresponds to Surgical & Medical Instruments & Apparatus.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on June 17, 2025 regarding PLUS THERAPEUTICS, INC. (PSTV).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.